Clinical Trials in Houston

Showing 12601-12620 of 15,366 trials

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

NCT00042328

The purpose of this research is to study the pharmacology (how the body handles this drug) of valacyclovir in children receiving treatment for cancer. This study will last approximately 7 days.

Neoplasms

Baylor College of Medicine30 participantsStarted Aug 2001

Houston, Texas, United States

TERMINATEDPhase 1< 1 mile

A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies

NCT00475917

The purpose of this study is to determine a safe dose of XL844 in combination with gemcitabine, how often it should be taken, and how well people with cancer tolerate the combination of gemcitabine and XL844.

CancerLymphoma

Exelixis28 participantsStarted May 2007

New York, New York, United States • Houston, Texas, United States

COMPLETED< 1 mile

TAXUS Libertē Post Approval Study

NCT00997503

The TAXUS Libertē Post-Approval Study is an FDA-mandated prospective, multi-center study designed to collect real-world safety and clinical outcomes in approximately 4,200 patients receiving one or more TAXUS Liberté Paclitaxel-Eluting Stents and prasugrel as part of a dual antiplatelet therapy (DAPT) drug regimen. This study will also contribute patient data to an FDA-requested and industry-sponsored research study that will evaluate the optimal duration of dual antiplatelet therapy (DAPT Study).

Coronary Artery Disease

Boston Scientific Corporation4,199 participantsStarted Dec 2009

Mesa, Arizona, United States • Jonesboro, Arkansas, United States • Jonesboro, Arkansas, United States +79 more locations

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies

TAXUS Libertē Post Approval Study

Find Trials by Condition in Houston

The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD)

Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors

An Open-Label Study to Evaluate Retreatment With LIPO-202

Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age

Familial Intracranial Aneurysm Study II

Talking Card for Asthma

Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer